Glaxo Wellcome withdraws Raxar

摘要

Glaxo Wellcome announced on October 27 that it is withdrawing its oral quinolone antubiotic grepafloxacin (Raxar) from the market worldwide with immediate effect. The which is voluntary, is a result of "emerging safety concerns."